Universal Health Services, Inc. (UHS)
NYSE: UHS · Real-Time Price · USD
162.54
-16.97 (-9.45%)
At close: Apr 28, 2026, 4:00 PM EDT
163.48
+0.94 (0.58%)
After-hours: Apr 28, 2026, 7:59 PM EDT
Universal Health Services Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for Universal Health Services stock have an average target of 230.27, with a low estimate of 185 and a high estimate of 302. The average target predicts an increase of 41.67% from the current stock price of 162.54.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Universal Health Services stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Hold | 7 | 7 | 8 | 8 | 7 | 6 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 12 | 13 | 13 | 12 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $268 → $238 | Buy | Maintains | $268 → $238 | +46.43% | Apr 28, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $235 → $212 | Hold | Maintains | $235 → $212 | +30.43% | Mar 2, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $250 → $229 | Hold | Maintains | $250 → $229 | +40.89% | Feb 27, 2026 |
| Barclays | Barclays | Buy Maintains $262 → $268 | Buy | Maintains | $262 → $268 | +64.88% | Feb 26, 2026 |
| Barclays | Barclays | Buy Maintains $263 → $262 | Buy | Maintains | $263 → $262 | +61.19% | Jan 22, 2026 |
Financial Forecast
Revenue This Year
18.70B
from 17.36B
Increased by 7.67%
Revenue Next Year
19.63B
from 18.70B
Increased by 4.99%
EPS This Year
23.71
from 23.10
Increased by 2.62%
EPS Next Year
25.83
from 23.71
Increased by 8.96%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 19.6B | 20.9B | ||||||
| Avg | 18.7B | 19.6B | ||||||
| Low | 17.5B | 18.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 13.0% | 11.6% | ||||||
| Avg | 7.7% | 5.0% | ||||||
| Low | 0.9% | -4.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 25.73 | 29.43 | ||||||
| Avg | 23.71 | 25.83 | ||||||
| Low | 21.88 | 23.28 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 11.4% | 24.2% | ||||||
| Avg | 2.6% | 9.0% | ||||||
| Low | -5.3% | -1.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.